Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).


CSE:RVV - Post by User

Comment by Trippedstockson Nov 24, 2020 10:18pm
196 Views
Post# 31967219

RE:RE:Clinical trials - recruiting def.

RE:RE:Clinical trials - recruiting def.
you are right, we need an update from the company after all the clinical trial website updates. It says updated Nov 24, but I haven't found a change yet.

When are they required to update shareholders on trial progression?

Interm analysis is when? 28 days after randomization? "Following completion of the treatment course, follow up assessments will be performed by a study nurse 14, 28, 42, and 60 days following the end of treatment." So when is the analysis?

In the Dr. Yoyo interview they said it was the 200mg dose that would be selected. He let that slip incase you missed it. They know....

Is everyone gonna continue accepting penny flips?

But hey.... I was told to relax.... Maybe I won't post 24 times in 48 hours over the next week like our chilled out coolaid friend here.

Maybe I'll spend tomorrow harrassing the trial sites on the phone for just the slightest bit of information.

Nawwwww I'll spend tomorrow bringing this to Michael Jordan levels!
<< Previous
Bullboard Posts
Next >>